Montréal, December 9, 2016 – Daniel Coderre, President and CEO of Génome Québec, is proud to announce that five Québec research teams have been awarded funding under the 2015 Disruptive Innovation in Genomics Competition.

“The expertise and leading-edge infrastructures now available here in Québec make it possible for genomics technology to unleash its tremendous potential for developing innovative solutions in the treatment and diagnosis of diseases. Québec’s outstanding performance in this competition is a clear indication that university research is a thriving sector with significant economic potential.” Daniel Coderre, President and CEO, Génome Québec

The five Québec projects:

Laser-assisted single-cell genomics
Project Leader: Santiago Costantino, Hôpital Maisonneuve-Rosemont

Single exosome multi-omic analysis
Project Leader: David Juncker, McGill University

The RNA zip code discovery pipeline: Emerging tools for targeting therapeutic molecules at subcellular resolution
Project Leader: Éric Lécuyer, Montreal Clinical Research Institute (IRCM)

Plasmonic PCR: Rapid diagnostics through plasmonics
Project Leader: Mark Trifiro, Jewish General Hospital

A cell micro-factory platform for in vivo biosynthesis and delivery of genetically encoded natural products and synthetic antibodies
Project Leader: Michael Tyers, Université de Montréal

To read the press release, click here.